JNJ - Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand.
As of May 15, 2026: spot at $227.34, ATM IV 21.5%, max pain $220.00, net GEX $37.6M.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Market Cap
- $554.67B
- P/E Ratio
- 26.78
- Beta
- 0.26
- 52-Week Range
- 147.33-251.71
- Dividend Yield
- $5.20
- CEO
- Joaquin Duato
- Employees
- 138,100
- IPO Date
- Jan 2, 1943
- Exchange
- NYSE
What JNJ Looks Like to Options Traders Today
IV rank of 54.1% sits near the 1-year median, where strategy choice depends on directional conviction and the event calendar rather than vol regime alone; positive net gamma exposure ($37.6M) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.010) is roughly flat across the wings.
What This Page Covers
The JNJ overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked JNJ overview questions
- What is JNJ?
- JNJ is the ticker symbol for Johnson & Johnson, a listed security. Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. Listed on NYSE. JNJ is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the JNJ options snapshot look like today?
- As of May 15, 2026, the JNJ options snapshot shows spot at $227.34, ATM IV 21.5%, IV rank 54.1%, max pain $220.00, net GEX $37.6M, expected move 6.17%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are JNJ's key statistics?
- Johnson & Johnson (JNJ) carries a market capitalization of $554.67B, trailing P/E ratio of 26.78, beta of 0.26 relative to the broader market, 52-week range of 147.33-251.71. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does JNJ belong to?
- Johnson & Johnson operates in the Healthcare sector, in the Drug Manufacturers - General industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare JNJ's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the JNJ data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).